ENVB
Enveric Biosciences, Inc.Company Information
- Company Name
- Enveric Biosciences, Inc.
- CIK
- CIK0000890821
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ENVB: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ENVB
SEC filing data through
Insider Sentiment
- Last purchase
- 2023-09-15
- Last sale
- —
- Shares purchased (TTM)
- 1,000
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 501,470
- Shares outstanding
- 3,987,084
- Ownership
- 12.58%
Earnings Market Reaction
- Filing date
- 2026-08-14
- Price on filing date
- —
- 1-month reaction
- -9.45%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | ||||||||||||||||||
| Cash | 8 | 5 | 5 | 4 | 3 | 4 | 2 | 3 | 4 | 6 | 2 | 4 | ||||||
| Prepaid Expense And Other Assets Current | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 1 | 2 | 2 | 1 | 2 | ||||||
| Assets Current | 9 | 5 | 5 | 4 | 3 | 5 | 3 | 4 | 6 | 8 | 4 | 6 | ||||||
Assets Noncurrent | ||||||||||||||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | ||||||
| Goodwill | - | - | - | - | - | - | - | - | - | - | - | 0 | ||||||
| Intangible Assets Net Excluding Goodwill | - | - | - | - | - | - | - | - | - | 0 | 0 | - | ||||||
| Finite Lived Intangible Assets Net | - | - | - | - | - | - | 0 | 0 | 0 | - | 0 | - | ||||||
| Deferred Costs | 0 | 0 | - | - | - | - | - | - | - | - | - | - | ||||||
| Assets Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | ||||||
| Assets | 9 | 6 | 5 | 4 | 4 | 5 | 3 | 5 | 6 | 9 | 4 | 7 | ||||||
Liabilities Current | ||||||||||||||||||
| Accounts Payable Current | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 2 | 1 | 1 | ||||||
| Other Liabilities Current | - | - | 0 | - | - | - | 0 | 0 | 0 | 0 | 0 | 1 | ||||||
| Accounts Payable And Other Accrued Liabilities Current | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - | - | - | - | - | ||||||
| Liabilities Current | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 4 | ||||||
| Accrued Liabilities Current | - | - | 0 | - | - | - | 1 | 0 | 0 | 0 | 1 | 2 | ||||||
Stockholders Equity | ||||||||||||||||||
| Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 128 | 122 | 120 | 117 | 114 | 113 | 108 | 107 | 107 | 106 | 101 | 96 | ||||||
| Stockholders Equity Note Subscriptions Receivable | - | - | - | - | - | - | - | - | - | - | -2 | - | ||||||
| Retained Earnings Accumulated Deficit | -120 | -116 | -115 | -113 | -111 | -108 | -106 | -103 | -101 | -99 | -96 | -93 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | ||||||
| Stockholders Equity | 8 | 5 | 4 | 3 | 2 | 4 | 2 | 4 | 5 | 6 | 2 | 2 | ||||||
| Liabilities And Stockholders Equity | 9 | 6 | 5 | 4 | 4 | 5 | 3 | 5 | 6 | 9 | 4 | 7 | ||||||
| Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Preferred Stock Shares Authorized | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | 20 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | ||||||
| Common Stock Shares Authorized | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | ||||||
| Common Stock Shares Issued | 4 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
| Shares Outstanding | 4 | 2 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||||
Select a line item above to chart it.
Recent filings
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
- 10-QFiled
- 10-QFiled
- 10-KFiled
- 10-QFiled
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialEnveric Biosciences, Inc. (ENVB) — SEC Financial Statements & Analysis
Enveric Biosciences, Inc. (ENVB) is a pharmaceutical preparations company, incorporated in DE. Enveric Biosciences, Inc. trades on Nasdaq as: ENVB. Enveric Biosciences, Inc. (ENVB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14. Based on that filing, Enveric Biosciences, Inc. carries a market cap of $5.50M, a P/E ratio of -0.63x, a P/B ratio of 0.68x, an enterprise value of $-2.79M, and an EV/EBITDA multiple of 0.33x. On profitability, it posts a Return on Equity (ROE) of -170.04% and a Return on Assets (ROA) of -139.75%. Per share, it reports EPS of $-2.19, diluted EPS of $-2.19, free cash flow per share of $-2.15, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of -12.21% year-over-year and EPS growth of -95.24% year-over-year. On the balance sheet, it maintains a current ratio of 10.21x, a quick ratio of 9.63x, working capital of $7.93M, a debt-to-equity ratio of 0.11x, a debt ratio of 0.1, an interest coverage ratio of -7800.25x, free cash flow of $-8.56M (TTM), and net debt of $-8.30M. Figures sourced from SEC EDGAR.
- Market Cap
- $5.50M
- P/E TTM
- -0.63x
- EPS TTM
- $-2.19
- P/B TTM
- 0.68x
- ROE TTM
- -170.04%
- ROA TTM
- -139.75%
- Debt To Equity
- 0.11x
- Free Cash Flow TTM
- $-8.56M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is Enveric Biosciences, Inc. in?
Enveric Biosciences, Inc. (ENVB) operates in the Pharmaceutical Preparations industry.
What exchange does ENVB trade on?
Enveric Biosciences, Inc. (ENVB) trades on the Nasdaq.
Where is Enveric Biosciences, Inc. incorporated?
Enveric Biosciences, Inc. is incorporated in DE.
When was Enveric Biosciences, Inc. (ENVB)'s most recent SEC filing?
Enveric Biosciences, Inc. (ENVB)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-14.
What is ENVB's market cap?
Enveric Biosciences, Inc. (ENVB) has a market capitalization of $5.50M as of 2026-06-30.
What is ENVB's EPS (earnings per share)?
Enveric Biosciences, Inc. (ENVB)'s trailing twelve month EPS is $-2.19 as of 2026-06-30.
What is ENVB's ROE (return on equity)?
Enveric Biosciences, Inc. (ENVB)'s trailing twelve month Return on Equity (ROE) is -170.04% as of 2026-06-30.
What is ENVB's ROA (return on assets)?
Enveric Biosciences, Inc. (ENVB)'s trailing twelve month Return on Assets (ROA) is -139.75% as of 2026-06-30.
What is ENVB's EV/EBITDA?
Enveric Biosciences, Inc. (ENVB)'s trailing twelve month EV/EBITDA is 0.33x as of 2026-06-30.